Products
-
Sodium PicosulfateCAS:1307301-38-7
-
EpalrestatCAS:82159-09-9
-
AgomelatineCAS:138112-76-2
-
SulindacCAS:38194-50-2
-
Risdiplam*CAS:1825352-65-5
-
DydrogesteroneCAS:152-62-5
Certification:Japanese DMF
-
EzetimibeCAS:163222-33-1
Certification:Japanese DMF
-
Roxadustat*CAS:808118-40-3
Certification:Japanese DMF
-
Rimegepant*CAS:1289023-67-1
-
Ubrogepant*CAS:1374248-77-7
-
Elacestrant*CAS:722533-56-4
-
AT037
CPG 2216CAS:332437-00-0
Product Pipeline
-
R&D
-
Pilot
-
Validation
-
DMF file
-
Commercial
-
Peptides
-
Small Molecules
-
Oligonucleotides
-
Bivalirudin
-
Cetrorelix Acetate
-
Eptifibatide
-
Lanreotide Acetate
-
Octreotide Acetate
-
Thymalfasin
-
Atosiban Acetate
-
Desmopressin Acetate
-
Liraglutide*
-
Semaglutide*
-
Tirzepatide*
-
Edotreotide
-
Oxytocin
-
Retatrutide*
-
Teriparatide
-
Difelikefalin*
-
Pegcetacoplan*
-
Setmelanotide*
-
Teduglutide
-
Ziconotide
-
Atorvastatin Calcium
-
Fulvestrant
-
Oseltamivir Phosphate
-
Agomelatine
-
Alogliptin Benzoate*
-
Epalrestat
-
Sodium Picosulfate
-
Sulindac
-
Risdiplam*
-
Dydrogesterone
-
Elacestrant*
-
Ezetimibe
-
Rimegepant*
-
Roxadustat*
-
Ubrogepant*
-
Nusinersen*
-
CPG 1018
-
CPG 2007
-
CPG 2216
-
Givosiran*
-
Inclisiran*
-
Patisiran*
-
Vutrisiran*
*Disclaimer: Due to the limitation of patent protection, commercial production and sales will not be carried out for the time being, and will only be used for scientific research and administrative approval.
